156 related articles for article (PubMed ID: 6783287)
21. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
Moriyama K; Wiener-Kronish JP; Sawa T
Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
[TBL] [Abstract][Full Text] [Related]
22. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
[TBL] [Abstract][Full Text] [Related]
23. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
Pier G
Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
[TBL] [Abstract][Full Text] [Related]
24. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
25. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity.
Sabharwal N; Chhibber S; Harjai K
Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605
[TBL] [Abstract][Full Text] [Related]
26. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM
Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
[TBL] [Abstract][Full Text] [Related]
27. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
[TBL] [Abstract][Full Text] [Related]
28. Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum.
Drake D; Montie TC
Can J Microbiol; 1987 Sep; 33(9):755-63. PubMed ID: 3121159
[TBL] [Abstract][Full Text] [Related]
29. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
Sokalska M; Maresz-Babczyszyn J
Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
[TBL] [Abstract][Full Text] [Related]
30. Impact of molecular biology on Pseudomonas aeruginosa immunization.
Pennington JE
J Hosp Infect; 1988 Feb; 11 Suppl A():96-102. PubMed ID: 2896754
[TBL] [Abstract][Full Text] [Related]
31. Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.
Dimitracopoulos G; Bartell PF
Infect Immun; 1980 Nov; 30(2):402-8. PubMed ID: 6777303
[TBL] [Abstract][Full Text] [Related]
32. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
Jones RJ; Roe EA
Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
[TBL] [Abstract][Full Text] [Related]
33. Common protective antigen between Pseudomanas aeruginosa and Vibrio cholerae.
Yamamoto A; Homma JY; Ghoda A; Ishihara T; Takeuchi S
Jpn J Exp Med; 1979 Dec; 49(6):383-90. PubMed ID: 120454
[TBL] [Abstract][Full Text] [Related]
34. Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.
Kikuchi T; Crystal RG
J Clin Invest; 2001 Sep; 108(6):917-27. PubMed ID: 11560961
[TBL] [Abstract][Full Text] [Related]
35. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
Pier GB; Sidberry HF; Sadoff JC
Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
[TBL] [Abstract][Full Text] [Related]
36. Immunization with homologous Pseudomonas aeruginosa pili protects against ocular disease.
Rudner XL; Berk RS; Hazlett LD
Reg Immunol; 1993; 5(5):245-52. PubMed ID: 7908533
[TBL] [Abstract][Full Text] [Related]
37. Protection of immunosuppressed mice against translocation of Pseudomonas aeruginosa from the gut by oral immunization with recombinant Pseudomonas aeruginosa outer membrane protein I expressing Salmonella dublin.
Toth A; Schödel F; Duchêne M; Massarrat K; Blum B; Schmitt A; Domdey H; von Specht BU
Vaccine; 1994 Oct; 12(13):1215-21. PubMed ID: 7839727
[TBL] [Abstract][Full Text] [Related]
38. Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.
Pier GB; Markham RB
J Immunol; 1982 May; 128(5):2121-5. PubMed ID: 6174622
[TBL] [Abstract][Full Text] [Related]
39. Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.
Finke M; Muth G; Reichhelm T; Thoma M; Duchêne M; Hungerer KD; Domdey H; von Specht BU
Infect Immun; 1991 Apr; 59(4):1251-4. PubMed ID: 1706316
[TBL] [Abstract][Full Text] [Related]
40. Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain.
Bridge DR; Whitmire JM; Makobongo MO; Merrell DS
Int J Med Microbiol; 2016 Nov; 306(7):529-540. PubMed ID: 27476047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
